Viewing Study NCT01817751


Ignite Creation Date: 2025-12-24 @ 11:44 PM
Ignite Modification Date: 2026-03-02 @ 4:01 PM
Study NCT ID: NCT01817751
Status: COMPLETED
Last Update Posted: 2024-07-17
First Post: 2013-03-20
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma
Sponsor: Virginia Commonwealth University
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2013-04-11
Start Date Type: ACTUAL
Primary Completion Date: 2020-08-27
Primary Completion Date Type: ACTUAL
Completion Date: 2023-05-12
Completion Date Type: ACTUAL
First Submit Date: 2013-03-20
First Submit QC Date: None
Study First Post Date: 2013-03-25
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2021-08-17
Results First Submit QC Date: None
Results First Post Date: 2021-10-28
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-06-24
Last Update Post Date: 2024-07-17
Last Update Post Date Type: ACTUAL